Efruxifermin Monoclonal Antibody
Efruxiferminis a research-grade recombinant antibody targeting Fibroblast growth factor 21. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Fibroblast growth factor 21, FGF-21, FGF21, UNQ3115/PRO10196
UniProt
Q9NSA1
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Mammal
Preservative
0.01M PBS, pH 7.4.
Isotype
Human IgG1 Fc domain linked to a modified human FGF21.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lyophilized exosomes from BxPC-3 cell line
Heat Shock Factor 2 Binding Protein (HSF2BP) (NM_007031) Human Mass Spec Standard
Merlin, NT (Moesin-ezrin-radixin-like Protein, ACN, BANF, Neurofibromin 2, Neurofibromin-2, NF2, Schwannomerlin, Schwannomin, SCH) (MaxLight 490)
Merlin, NT (Moesin-ezrin-radixin-like Protein, ACN, BANF, Neurofibromin 2, Neurofibromin-2, NF2, Schwannomerlin, Schwannomin, SCH) (MaxLight 490)
